ACOD1 and hepatocellular carcinoma: In summary, these findings suggest that the clinical analgesic-antipyretic drug ibuprofen could suppress HCC by targeting IRG1/itaconate-mediated T-cell exhaustion, and ibuprofen significantly improved the efficacy of anti-PD-1 antibody-based immunotherapy.